Interleukin-1β alters the sensitivity of cannabinoid CB1 receptors controlling glutamate transmission in the striatum

Neuroscience

Volumn 250, Issue , 2013, Pages 232-239

  De Chiara, V ^a,b   Motta, C ^a,b   Rossi, S ^a,b   Studer, V ^a,b   Barbieri, F ^a,b   Lauro, D ^a   Bernardi, G ^a,b   Centonze, D ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

Cytokines; Endocannabinoid system; Glutamate; Inflammation; Neurodegeneration; Synaptic transmission

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CANNABINOID 1 RECEPTOR; CHOLESTEROL; ENDOCANNABINOID; GLUTAMIC ACID; INTERLEUKIN 1BETA; PROTEIN KINASE C; VANILLOID RECEPTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BDNF GENE; BRAIN SLICE; CONTROLLED STUDY; CORPUS STRIATUM; GABAERGIC TRANSMISSION; GENE DELETION; LIPID COMPOSITION; LIPID MEMBRANE; LIPID RAFT; MALE; MOUSE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RECEPTOR BLOCKING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

2-ARACHIDONOYLGLYCEROL; 2AG; 4-(2-HYDROXYETHYL)-1-PIPERAZINEETHANESULFONIC ACID; 6-CYANO-7-NITROQUINOXALINE-2,3-DIONE; ACSF; AEA; ANADAMIDE; ARTIFICIAL CEREBROSPINAL FLUID; BDNF; BRAIN-DERIVED NEUROTROPHIC FACTOR; CANNABINOID CB1 RECEPTORS CONTROLLING GABA TRANSMISSION; CB1RS CONTROLLING GLUTAMATE TRANSMISSION; CB1RS((GABA)); CB1RS((GLU)); CNQX; CYTOKINES; DIMETHYL SULFOXIDE; DMSO; ECS; EGTA; ENDOCANNABINOID SYSTEM; ETHYLENE GLYCOL-BIS(Β-AMINOETHYL ETHER)-N,N,N′,N′-TETRA-ACETIC ACID; GLUTAMATE; HEPES; IL1Β; INFLAMMATION; INTERLEUKIN-1Β; MCD; METHYL-Β-CYCLODEXTRIN; N-METHYL-D-ASPARTATE; NEURODEGENERATION; NMDA; PHORBOL 12-MYRISTATE-13-ACETATE; PKC; PMA; PROTEIN KINASE C; SEPSCS; SIPSCS; SPONTANEOUS EXCITATORY POSTSYNAPTIC CURRENTS; SPONTANEOUS INHIBITORY POSTSYNAPTIC CURRENTS; SYNAPTIC TRANSMISSION; TRANSIENT RECEPTOR POTENTIAL VANILLOID 1; TRPV1; WILD-TYPE; WT;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DRONABINOL; ELECTROPHYSIOLOGICAL PROCESSES; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMIC ACID; INTERLEUKIN-1BETA; MALE; MEMBRANE MICRODOMAINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOSTRIATUM; PROTEIN KINASE C; RECEPTOR, CANNABINOID, CB1; RECEPTORS, GABA-B; SIGNAL TRANSDUCTION; SYNAPSES; SYNAPTIC TRANSMISSION; TRPV CATION CHANNELS;

EID: 84881630081     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.06.069     Document Type: Article

References (35)

1. Centonze D., Rossi S., De Chiara V., Prosperetti C., Battista N., Bernardi G., Mercuri N.B., Usiello A., Maccarrone M. Chronic cocaine sensitizes striatal GABAergic synapses to the stimulation of cannabinoid CB1 receptors. Eur J Neurosci 2007, 25:1631-1640.
2. Centonze D., Muzio L., Rossi S., Cavasinni F., De Chiara V., Bergami A., Musella A., D'Amelio M., Cavallucci V., Martorana A., Bergamaschi A., Cencioni M.T., Diamantini A., Butti E., Comi G., Bernardi G., Cecconi F., Battistini L., Furlan R., Martino G. Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis. J Neurosci 2009, 29:3442-3452.
3. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008, 9:46-56.
4. De Chiara V., Angelucci F., Rossi S., Musella A., Cavasinni F., Cantarella C., Mataluni G., Sacchetti L., Napolitano F., Castelli M., Caltagirone C., Bernardi G., Maccarrone M., Usiello A., Centonze D. Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum. J Neurosci 2010, 30:8127-8137.
5. De Chiara V., Errico F., Musella A., Rossi S., Mataluni G., Sacchetti L., Siracusano A., Castelli M., Cavasinni F., Bernardi G., Usiello A., Centonze D. Voluntary exercise and sucrose consumption enhance cannabinoid CB1 receptor sensitivity in the striatum. Neuropsychopharmacology 2010, 35:374-387.
6. Feinstein A. Neuropsychiatric syndromes associated with multiple sclerosis. J Neurol 2007, 254:II73-II76.
7. Freiman I., Anton A., Monyer H., Urbanski M.J., Szabo B. Analysis of the effects of cannabinoids on identified synaptic connections in the caudate-putamen by paired recordings in transgenic mice. J Physiol 2006, 575:789-806.
8. Gerdeman G., Lovinger D.M. CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum. J Neurophysiol 2001, 85:468-471.
9. Gobbi G., Bambico F.R., Mangieri R., Bortolato M., Campolongo P., Solinas M., Cassano T., Morgese M.G., Debonnel G., Duranti A., Tontini A., Tarzia G., Mor M., Trezza V., Goldberg S.R., Cuomo V., Piomelli D. Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc Natl Acad Sci U S A 2005, 102:18620-18625.
10. Haji N., Mandolesi G., Gentile A., Sacchetti L., Fresegna D., Rossi S., Musella A., Sepman H., Motta C., Studer V., De Chiara V., Bernardi G., Strata P., Centonze D. TNF-α-mediated anxiety in a mouse model of multiple sclerosis. Exp Neurol 2012, 237:296-303.
11. Kathuria S., Gaetani S., Fegley D., Valiño F., Duranti A., Tontini A., Mor M., Tarzia G., La Rana G., Calignano A., Giustino A., Tattoli M., Palmery M., Cuomo V., Piomelli D. Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 2003, 9:76-81.
12. Kawaguchi Y., Wilson C.J., Augood S.J., Emson P.C. Striatal interneurones: chemical physiological and morphological characterization. Trends Neurosci 1995, 18:527-535.
13. Kreitzer A.C., Malenka R.C. Dopamine modulation of state-dependent endocannabinoid release and long-term depression in the striatum. J Neurosci 2005, 25:10537-10545.
14. Maccarrone M., Rossi S., Bari M., De Chiara V., Fezza F., Musella A., Gasperi V., Prosperetti C., Bernardi G., Finazzi-Agrò A., Cravatt B.F., Centonze D. Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum. Nat Neurosci 2008, 11:152-159.
15. Maccarrone M., De Chiara V., Gasperi V., Viscomi M.T., Rossi S., Oddi S., Molinari M., Musella A., Finazzi-Agrò A., Centonze D. Lipid rafts regulate 2-arachidonoylglycerol metabolism and physiological activity in the striatum. J Neurochem 2009, 109:371-381.
16. Matyas F., Yanovsky Y., Mackie K., Kelsch W., Misgeld U., Freund T.F. Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia. Neuroscience 2006, 137:337-361.
17. Micale V., Cristino L., Tamburella A., Petrosino S., Leggio G.M., Drago F., Di Marzo V. Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels. Neuropsychopharmacology 2009, 34:593-606.
18. Miller A.H., Maletic V., Raison C.L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009, 65:732-741.
19. Musella A., De Chiara V., Rossi S., Prosperetti C., Bernardi G., Maccarrone M., Centonze D. TRPV1 channels facilitate glutamate transmission in the striatum. Mol Cell Neurosci 2009, 40:89-97.
20. Musella A., De Chiara V., Rossi S., Cavasinni F., Castelli M., Cantarella C., Mataluni G., Bernardi G., Centonze D. Transient receptor potential vanilloid 1 channels control acetylcholine/2-arachidonoylglicerol coupling in the striatum. Neuroscience 2010, 167:864-871.
21. Musumeci G., Grasselli G., Rossi S., De Chiara V., Musella A., Motta C., Studer V., Bernardi G., Haji N., Sepman H., Fresegna D., Maccarrone M., Mandolesi G., Centonze D. Transient receptor potential vanilloid 1 channels modulate the synaptic effects of TNF-α and of IL-1β in experimental autoimmune encephalomyelitis. Neurobiol Dis 2011, 43:669-677.
22. Narushima M., Uchigashima M., Fukaya M., Matsui M., Manabe T., Hashimoto K., Watanabe M., Kano M. Tonic enhancement of endocannabinoid-mediated retrograde suppression of inhibition by cholinergic interneuron activity in the striatum. J Neurosci 2007, 27:496-506.
23. Novotna A., Mares J., Ratcliffe S., Novakova I., Vachova M., Zapletalova O., Gasperini C., Pozzilli C., Cefaro L., Comi G., Rossi P., Ambler Z., Stelmasiak Z., Erdmann A., Montalban X., Klimek A., Davies P. A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols (Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis. Eur J Neurol 2011, 18:1122-1131. Sativex Spasticity Study Group.
24. Oddi S., Dainese E., Sandiford S., Fezza F., Lanuti M., Chiurchiù V., Totaro A., Catanzaro G., Barcaroli D., De Laurenzi V., Centonze D., Mukhopadhyay S., Selent J., Howlett A.C., Maccarrone M. Effects of palmitoylation of Cys(415) in helix 8 of the CB(1) cannabinoid receptor on membrane localization and signalling. Br J Pharmacol 2012, 165:2635-2651.
25. Patel S., Hillard C.J. Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling. J Pharmacol Exp Ther 2006, 318:304-311.
26. Pryce G., Ahmed Z., Hankey D.J., Jackson S.J., Croxford J.L., Pocock J.M., Ledent C., Petzold A., Thompson A.J., Giovannoni G., Cuzner M.L., Baker D. Cannabinoids inhibit neurodegeneration in models of multiple sclerosis. Brain 2003, 126:2191-2202.
27. Rossi S., De Chiara V., Musella A., Kusayanagi H., Mataluni G., Bernardi G., Usiello A., Centonze D. Chronic psychoemotional stress impairs cannabinoid-receptor-mediated control of GABA transmission in the striatum. J Neurosci 2008, 28:7284-7292.
28. Rossi S., De Chiara V., Musella A., Sacchetti L., Cantarella C., Castelli M., Cavasinni F., Motta C., Studer V., Bernardi G., Cravatt B.F., Maccarrone M., Usiello A., Centonze D. Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition. Mol Pharmacol 2010, 78:260-268.
29. Rossi S., Furlan R., De Chiara V., Muzio L., Musella A., Motta C., Studer V., Cavasinni F., Bernardi G., Martino G., Cravatt B.F., Lutz B., Maccarrone M., Centonze D. Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitis. Brain Behav Immun 2011, 25:1242-1248.
30. Rossi S., Furlan R., De Chiara V., Motta C., Studer V., Mori F., Musella A., Bergami A., Muzio L., Bernardi G., Battistini L., Martino G., Centonze D. Interleukin-1β causes synaptic hyperexcitability in multiple sclerosis. Ann Neurol 2012, 71:76-83.
31. Rossi S., Studer V., Motta C., De Chiara V., Barbieri F., Bernardi G., Centonze D. Inflammation inhibits GABA transmission in multiple sclerosis. Mult Scler 2012, 18:1633-1635.
32. Rossi S., Sacchetti L., Napolitano F., De Chiara V., Motta C., Studer V., Musella A., Barbieri F., Bari M., Bernardi G., Maccarrone M., Usiello A., Centonze D. Interleukin-1β causes anxiety by interacting with the endocannabinoid system. J Neurosci 2012, 32:13896-13905.
33. Sikand P., Premkumar L.S. Potentiation of glutamatergic synaptic transmission by protein kinase C-mediated sensitization of TRPV1 at the first sensory synapse. J Physiol 2007, 581:631-647.
34. Suzuki S., Kiyosue K., Hazama S., Ogura A., Kashihara M., Hara T., Koshimizu H., Kojima M. Brain-derived neurotrophic factor regulates cholesterol metabolism for synapse development. J Neurosci 2007, 27:6417-6427.
35. Uchigashima M., Narushima M., Fukaya M., Katona I., Kano M., Watanabe M. Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum. J Neurosci 2007, 27:3663-3676.